Prospects and challenges for the application of tissue engineering technologies in the treatment of bone infections

Abstract

Osteomyelitis is a devastating disease caused by microbial infection in deep bone tissue. Its high recurrence rate and impaired restoration of bone deficiencies are major challenges in treatment. Microbes have evolved numerous mechanisms to effectively evade host intrinsic and adaptive immune attacks to persistently localize in the host, such as drug-resistant bacteria, biofilms, persister cells, intracellular bacteria, and small colony variants (SCVs). Moreover, microbial-mediated dysregulation of the bone immune microenvironment impedes the bone regeneration process, leading to impaired bone defect repair. Despite advances in surgical strategies and drug applications for the treatment of bone infections within the last decade, challenges remain in clinical management. The development and application of tissue engineering materials have provided new strategies for the treatment of bone infections, but a comprehensive review of their research progress is lacking. This review discusses the critical pathogenic mechanisms of microbes in the skeletal system and their immunomodulatory effects on bone regeneration, and highlights the prospects and challenges for the application of tissue engineering technologies in the treatment of bone infections. It will inform the development and translation of antimicrobial and bone repair tissue engineering materials for the management of bone infections.

References

[1] Zhang S et al. Immunomodulatory biomaterials against bacterial infections: progress, challenges, and future perspectives. The Innovation, 2023, 4: 100503

[2] Zelmer AR, Nelson R, Richter K, Atkins GJ. Can intracellular Staphylococcus aureus in osteomyelitis be treated using current antibiotics? A systematic review and narrative synthesis. Bone Res., 2022, 10: 53

[3] Masters EA et al. Evolving concepts in bone infection: redefining “biofilm”, “acute vs. chronic osteomyelitis”, “the immune proteome” and “local antibiotic therapy”. Bone Res, 2019, 7: 20

[4] Zalavras CG, Patzakis MJ. Open fractures: evaluation and management. J. Am. Acad. Orthop. Surg., 2003, 11: 212-219

[5] Metsemakers WJ et al. Infection after fracture fixation: current surgical and microbiological concepts. Injury, 2018, 49: 511-522

[6] Schwarz EM et al. 2018 International consensus meeting on musculoskeletal infection: research priorities from the general assembly questions. J. Orthop. Res., 2019, 37: 997-1006

[7] Ramage G, Tunney MM, Patrick S, Gorman SP, Nixon JR. Formation of propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials. Biomaterials, 2003, 24: 3221-3227

[8] Veis DJ, Cassat JE. Infectious osteomyelitis: marrying bone biology and microbiology to shed new light on a persistent clinical challenge. J. Bone Miner. Res., 2021, 36: 636-643

[9] Conterno, L. O. & Turchi, M. D. Antibiotics for treating chronic osteomyelitis in adults. Cochrane Database Syst. Rev. https://doi.org/10.1002/14651858.CD004439.pub3 (2013).

[10] Calhoun J, Manring MM, Shirtliff M. Osteomyelitis of the long bones. Semin. Plast. Surg., 2009, 23: 059-072

[11] Fantoni M, Taccari F, Giovannenze F. Systemic antibiotic treatment of chronic osteomyelitis in adults. Eur. Rev. Med. Pharmacol. Sci., 2019, 23: 258-270

[12] Calhoun JH, Manring MM. Adult osteomyelitis. Infect. Dis. Clin. North Am., 2005, 19: 765-786

[13] Cui Y et al. Dual-functional composite scaffolds for inhibiting infection and promoting bone regeneration. Mater. Today Bio., 2022, 16

[14] Xiong Y et al. The role of the immune microenvironment in bone, cartilage, and soft tissue regeneration: from mechanism to therapeutic opportunity. Mil. Med. Res., 2022, 9: 65

[15] Salhotra A, Shah HN, Levi B, Longaker MT. Mechanisms of bone development and repair. Nat. Rev. Mol. Cell Biol., 2020, 21: 696-711

[16] Wang X, Wang Z, Fu J, Huang K, Xie Z. Induced membrane technique for the treatment of chronic hematogenous tibia osteomyelitis. BMC Musculoskelet. Disord., 2017, 18

[17] Tong K et al. Masquelet technique versus Ilizarov bone transport for reconstruction of lower extremity bone defects following posttraumatic osteomyelitis. Injury, 2017, 48: 1616-1622

[18] Khare D, Basu B, Dubey AK. Electrical stimulation and piezoelectric biomaterials for bone tissue engineering applications. Biomaterials, 2020, 258: 120280

[19] Pacheco H et al. Tissue engineering scaffold for sequential release of vancomycin and rhBMP2 to treat bone infections: release of vancomycin and rhBMP2 to treat bone infections. J. Biomed. Mater. Res. A, 2014, 102: 4213-4223

[20] Xie CM et al. Silver nanoparticles and growth factors incorporated hydroxyapatite coatings on metallic implant surfaces for enhancement of osteoinductivity and antibacterial properties. ACS Appl. Mater. Interfaces, 2014, 6: 8580-8589

[21] Lian X et al. Antibacterial and biocompatible properties of vancomycin-loaded nano-hydroxyapatite/collagen/poly (lactic acid) bone substitute. Prog. Nat. Sci. Mater. Int, 2013, 23: 549-556

[22] Rigby KM, DeLeo FR. Neutrophils in innate host defense against Staphylococcus aureus infections. Semin. Immunopathol., 2012, 34: 237-259

[23] Bröker B, Mrochen D, Péton V. The T cell response to Staphylococcus aureus. Pathogens, 2016, 5: 31

[24] Lüthje FL et al. Receptor activator of nuclear factor kappa-B ligand is not regulated during chronic osteomyelitis in pigs. J. Comp. Pathol, 2020, 179: 7-24

[25] Libraty DH, Patkar C, Torres B. Staphylococcus aureus reactivation osteomyelitis after 75 years. N. Engl. J. Med., 2012, 366: 481-482

[26] Fraunholz M, Sinha B. Intracellular Staphylococcus aureus: live-in and let die. Front. Cell. Infect. Microbiol., 2012, 2: 43

[27] Garzoni C, Kelley WL. Return of the Trojan horse: intracellular phenotype switching and immune evasion by Staphylococcus aureus. EMBO Mol. Med., 2011, 3: 115-117

[28] Edwards AM, Potts JR, Josefsson E, Massey RC. Staphylococcus aureus host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPA. PLoS Pathog, 2010, 6: e1000964

[29] Ellington JK et al. Intracellular Staphylococcus aureus: a mechanism for the indolence of osteomyelitis. J. Bone Joint Surg. Br., 2003, 85-B: 918-921

[30] Josse J, Velard F, Gangloff SC. Staphylococcus aureus vs. osteoblast: relationship and consequences in osteomyelitis. Front. Cell. Infect. Microbiol., 2015, 5: 85

[31] Münzenmayer L et al. Influence of sae-regulated and agr-regulated factors on the escape of Staphylococcus aureus from human macrophages: S. aureus factors for macrophage escape. Cell. Microbiol., 2016, 18: 1172-1183

[32] Proctor RA et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol., 2006, 4: 295-305

[33] Cai Y et al. The role of Staphylococcus aureus small colony variants in intraosseous invasion and colonization in periprosthetic joint infection. Bone Jt. Res., 2022, 11: 843-853

[34] You LD, Weinbaum S, Cowin SC, Schaffler MB. Ultrastructure of the osteocyte process and its pericellular matrix. Anat. Rec. A. Discov. Mol. Cell. Evol. Biol., 2004, 278A: 505-513

[35] Gatica D, Lahiri V, Klionsky DJ. Cargo recognition and degradation by selective autophagy. Nat. Cell Biol., 2018, 20: 233-242

[36] Zoller SD et al. Evading the host response: Staphylococcus “hiding” in cortical bone canalicular system causes increased bacterial burden. Bone Res, 2020, 8: 43

[37] Masters EA et al. Staphylococcus aureus cell wall biosynthesis modulates bone invasion and osteomyelitis pathogenesis. Front. Microbiol., 2021, 12: 723498

[38] de Mesy Bentley KL, MacDonald A, Schwarz EM, Oh I. Chronic osteomyelitis with Staphylococcus aureus deformation in submicron canaliculi of osteocytes: a case report. J. Bone Joint Surg. Am, 2018, 8: e8

[39] Teng H et al. Novel Insights into the evolution of the caveolin superfamily and mechanisms of antiapoptotic effects and cell proliferation in lamprey. Dev. Comp. Immunol., 2019, 95: 118-128

[40] Karygianni L, Ren Z, Koo H, Thurnheer T. Biofilm matrixome: extracellular components in structured microbial communities. Trends Microbiol., 2020, 28: 668-681

[41] Kremers HM et al. Trends in the epidemiology of osteomyelitis: a population-based study, 1969 to 2009. J. Bone Jt. Surg., 2015, 97: 837-845

[42] Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N. Engl. J. Med., 2004, 351: 1645-1654

[43] Yousif A, Jamal MA, Raad I. Biofilm-based central line-associated bloodstream infections. Adv. Exp. Med. Biol., 2015, 830: 157-179

[44] Mottola C et al. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections. BMC Microbiol., 2016, 16: 119

[45] Guo H et al. Biofilm and small colony variants— an update on Staphylococcus aureus strategies toward drug resistance. Int. J. Mol. Sci., 2022, 23: 1241

[46] Jamal M et al. Bacterial biofilm and associated infections. J. Chin. Med. Assoc., 2018, 81: 7-11

[47] Moormeier DE, Bayles KW. Staphylococcus aureus biofilm: a complex developmental organism. Mol. Microbiol., 2017, 104: 365-376

[48] Schilcher K, Horswill AR. Staphylococcal biofilm development: structure, regulation, and treatment strategies. Microbiol. Mol. Biol. Rev. MMBR, 2020, 84: e00026-19

[49] O’Neill E et al. A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J. Bacteriol., 2008, 190: 3835-3850

[50] Beaussart A, Feuillie C, El-Kirat-Chatel S. The microbial adhesive arsenal deciphered by atomic force microscopy. Nanoscale, 2020, 12: 23885-23896

[51] Mangwani N, Kumari S, Das S. Bacterial biofilms and quorum sensing: fidelity in bioremediation technology. Biotechnol. Genet. Eng. Rev., 2016, 32: 43-73

[52] Boles BR, Horswill AR. Staphylococcal biofilm disassembly. Trends Microbiol., 2011, 19: 449-455

[53] Lister JL, Horswill AR. Staphylococcus aureus biofilms: recent developments in biofilm dispersal. Front. Cell. Infect. Microbiol., 2014, 4: 178

[54] Carek PJ, Dickerson LM, Sack JL. Diagnosis and management of osteomyelitis. Am. Fam. Physician, 2001, 63: 2413-2420

[55] Cheng AG et al. Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog, 2010, 6: e1001036

[56] Hofstee MI et al. Three-dimensional in vitro Staphylococcus aureus abscess communities display antibiotic tolerance and protection from neutrophil clearance. Infect. Immun., 2020, 88: e00293-20

[57] Fey PD. Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections? Curr. Opin. Microbiol., 2010, 13: 610-615

[58] Kavanagh N et al. Staphylococcal osteomyelitis: disease progression, treatment challenges, and future directions. Clin. Microbiol. Rev., 2018, 31: e00084-17

[59] Otto M. Staphylococcus epidermidis — the ‘accidental’ pathogen. Nat. Rev. Microbiol., 2009, 7: 555-567

[60] Konto-Ghiorghi Y et al. Dual role for pilus in adherence to epithelial cells and biofilm formation in streptococcus agalactiae. PLoS Pathog, 2009, 5: e1000422

[61] Willett JLE et al. Comparative biofilm assays using enterococcus faecalis OG1RF identify new determinants of biofilm formation. mBio., 2021, 12: e01011-e01021

[62] Dale JL, Cagnazzo J, Phan CQ, Barnes AMT, Dunny GM. Multiple roles for enterococcus faecalis glycosyltransferases in biofilm-associated antibiotic resistance, cell envelope integrity, and conjugative transfer. Antimicrob. Agents Chemother., 2015, 59: 4094-4105

[63] Dale JL, Nilson JL, Barnes AMT, Dunny GM. Restructuring of enterococcus faecalis biofilm architecture in response to antibiotic-induced stress. Npj Biofilms Microbiomes, 2017, 3

[64] Pang Z. Antibiotic resistance in Pseudomonas aeruginosa_ mechanisms and alternative therapeutic strategies. Biotechnol. Adv., 2019, 37: 177-192

[65] Chirgwin K, Gleich S. Listeria monocytogenes osteomyelitis. Arch. Intern. Med, 1989, 149: 931-932

[66] Bariteau JT et al. Fungal osteomyelitis and septic arthritis. J. Am. Acad. Orthop. Surg., 2014, 22: 390-401

[67] Vazquez M. Osteomyelitis in children. Curr. Opin. Pediatr., 2002, 14: 112-115

[68] Epps H. Osteomyelitis in patients who have sickle-cell disease. Diagnosis and management. J. Bone Joint. Surg. Am., 1991, 73: 1281-1294

[69] Ho-Shui-Ling A et al. Bone regeneration strategies: engineered scaffolds, bioactive molecules and stem cells current stage and future perspectives. Biomaterials, 2018, 180: 143-162

[70] Chen Y et al. Effects of Pereskia aculeate miller petroleum ether extract on complete Freund’s adjuvant-induced rheumatoid arthritis in rats and its potential molecular mechanisms. Front. Pharmacol., 2022, 13: 869810

[71] Nightingale TD et al. Tuning the endothelial response: differential release of exocytic cargos from Weibel‐Palade bodies. J. Thromb. Haemost., 2018, 16: 1873-1886

[72] Zhou J et al. BLT1 in dendritic cells promotes Th1/Th17 differentiation and its deficiency ameliorates TNBS-induced colitis. Cell. Mol. Immunol., 2018, 15: 1047-1056

[73] Mussbacher M, Derler M, Basílio J, Schmid JA. NF-κB in monocytes and macrophages - an inflammatory master regulator in multitalented immune cells. Front. Immunol., 2023, 14: 1134661

[74] Vignais PV. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell. Mol. Life Sci. CMLS, 2002, 59: 1428-1459

[75] Newman H, Shih YV, Varghese S. Resolution of inflammation in bone regeneration: from understandings to therapeutic applications. Biomaterials, 2021, 277: 121114

[76] Alder KD et al. Intracellular Staphylococcus aureus in bone and joint infections: a mechanism of disease recurrence, inflammation, and bone and cartilage destruction. Bone, 2020, 141: 115568

[77] Krauss JL et al. Staphylococcus aureus infects osteoclasts and replicates intracellularly. mBio, 2019, 10: e02447-19

[78] Wong RMY et al. A systematic review on current osteosynthesis-associated infection animal fracture models. J. Orthop. Transl., 2020, 23: 8-20

[79] Laubach M et al. Clinical translation of a patient-specific scaffold-guided bone regeneration concept in four cases with large long bone defects. J. Orthop. Transl., 2022, 34: 73-84

[80] McNeill EP et al. Characterization of a pluripotent stem cell-derived matrix with powerful osteoregenerative capabilities. Nat. Commun., 2020, 11

[81] Mitra D, Whitehead J, Yasui OW, Leach JK. Bioreactor culture duration of engineered constructs influences bone formation by mesenchymal stem cells. Biomaterials, 2017, 146: 29-39

[82] Nandi SK et al. Understanding osteomyelitis and its treatment through local drug delivery system. Biotechnol. Adv., 2016, 34: 1305-1317

[83] Karki K, Sigdel S, Kafle S. Is it worth adding systemic antibiotics to inhalational tobramycin therapy to treat pseudomonas infections in cystic fibrosis? Cureus, 2021, 13: e17326

[84] Wen Q, Gu F, Sui Z, Su Z, Yu T. The process of osteoblastic infection by Staphylococcus aureus. Int. J. Med. Sci., 2020, 17: 1327-1332

[85] Zimmerli W, Sendi P. Orthopaedic biofilm infections. APMIS, 2017, 125: 353-364

[86] Govaert GAM et al. Diagnosing fracture-related infection: current concepts and recommendations. J. Orthop. Trauma, 2020, 34: 8-17

[87] Zhang D et al. Efficacy of novel nano-hydroxyapatite/polyurethane composite scaffolds with silver phosphate particles in chronic osteomyelitis. J. Mater. Sci. Mater. Med., 2019, 30: 59

[88] Murphy CM, Haugh MG, O’Brien FJ. The effect of mean pore size on cell attachment, proliferation and migration in collagen–glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials, 2010, 31: 461-466

[89] Masters EA et al. Skeletal infections: microbial pathogenesis, immunity and clinical management. Nat. Rev. Microbiol., 2022, 20: 385-400

[90] Parsons B, Strauss E. Surgical management of chronic osteomyelitis. Am. J. Surg., 2004, 188: 57-66

[91] Saavedra-Lozano J et al. Bone and joint infections. Pediatr. Infect. Dis. J., 2017, 36: 788-799

[92] Urish KL, Cassat JE. Staphylococcus aureus osteomyelitis: bone, bugs, and surgery. Infect. Immun., 2020, 88: e00932-19

[93] Lehar SM et al. Novel antibody-antibiotic conjugate eliminates intracellular S. aureus. Nature, 2015, 527: 323-328

[94] Wassif RK, Elkayal M, Shamma RN, Elkheshen SA. Recent advances in the local antibiotics delivery systems for management of osteomyelitis. Drug Deliv., 2021, 28: 2392-2414

[95] Liu Y, Li X, Liang A. Current research progress of local drug delivery systems based on biodegradable polymers in treating chronic osteomyelitis. Front. Bioeng. Biotechnol., 2022, 10: 1042128

[96] Inzana JA, Schwarz EM, Kates SL, Awad HA. Biomaterials approaches to treating implant-associated osteomyelitis. Biomaterials, 2016, 81: 58-71

[97] Li J et al. Transformation of arginine into zero-dimensional nanomaterial endows the material with antibacterial and osteoinductive activity. Sci. Adv., 2023, 9: eadf8645

[98] Ghosh S et al. A potent antibiotic-loaded bone-cement implant against staphylococcal bone infections. Nature Biomed. Eng., 2022, 6: 1180-1195

[99] Wang W, Yeung KW. Bone grafts and biomaterials substitutes for bone defect repair: a review. Bioact. Mater., 2017, 2: 224-247

[100] Zhang M et al. 3D printing of Haversian bone–mimicking scaffolds for multicellular delivery in bone regeneration. Sci. Adv., 2020, 6: eaaz6725

[101] Li Y et al. A review on functionally graded materials and structures via additive manufacturing: from multi‐scale design to versatile functional properties. Adv. Mater. Technol., 2020, 5: 1900981

[102] Sun J, Tan H. Alginate-based biomaterials for regenerative medicine applications. Materials (Basel), 2013, 6: 1285-1309

[103] Lu G et al. An instantly fixable and self-adaptive scaffold for skull regeneration by autologous stem cell recruitment and angiogenesis. Nat. Commun., 2022, 13

[104] Yuan B et al. A biomimetically hierarchical polyetherketoneketone scaffold for osteoporotic bone repair. Sci. Adv., 2020, 6: eabc4704

[105] Ren Y et al. Photoresponsive materials for antibacterial applications. Cell Rep. Phys. Sci., 2020, 1: 100245

[106] Yang K et al. Bio-functional design, application and trends in metallic biomaterials. Int. J. Mol. Sci., 2017, 19: 24

[107] Goriainov V, Cook R, Latham JM, Dunlop DG, Oreffo ROC. Bone and metal: an orthopaedic perspective on osseointegration of metals. Acta Biomater., 2014, 10: 4043-4057

[108] Sukhanova A et al. Dependence of nanoparticle toxicity on their physical and chemical properties. Nanoscale Res. Lett., 2018, 13

[109] Shaikh S et al. Mechanistic insights into the antimicrobial actions of metallic nanoparticles and their implications for multidrug resistance. Int. J. Mol. Sci., 2019, 20: 2468

[110] Lemire, J. A. & Turner, R. J. Mechanisms underlying the antimicrobial capacity of metals. in Stress and Environmental Regulation of Gene Expression and Adaptation in Bacteria (ed. De Bruijn, F. J.) 215–224 (Wiley, 2016). https://doi.org/10.1002/9781119004813.ch18.

[111] Warnes SL, Keevil CW. Lack of involvement of Fenton chemistry in death of methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus and destruction of their genomes on wet or dry copper alloy surfaces. Appl. Environ. Microbiol., 2016, 82: 2132-2136

[112] Spirescu VA, Chircov C, Grumezescu AM, Vasile B. Inorganic nanoparticles and composite films for antimicrobial therapies. Int. J. Mol. Sci., 2021, 22: 4595

[113] Vallet‐Regí M, Ruiz‐Hernández E. Bioceramics: from bone regeneration to cancer nanomedicine. Adv. Mater., 2011, 23: 5177-5218

[114] Shuai C et al. Structure and properties of nano-hydroxypatite scaffolds for bone tissue engineering with a selective laser sintering system. Nanotechnology, 2011, 22: 285703

[115] Zhao C, Liu W, Zhu M, Wu C, Zhu Y. Bioceramic-based scaffolds with antibacterial function for bone tissue engineering: a review. Bioact. Mater., 2022, 18: 383-398

[116] Li S et al. Antiba. Adv. Sci., 2018, 5: 1700527

[117] Oda Y, Kanaoka S, Sato T, Aoshima S, Kuroda K. Block versus random amphiphilic copolymers as antibacterial agents. Biomacromolecules, 2011, 12: 3581-3591

[118] Zhou H et al. Stimuli-responsive peptide hydrogels for biomedical applications. J. Mater. Chem. B, 2024, 12: 1748-1774

[119] Liu C et al. Research progress of polyphenols in nanoformulations for antibacterial application. Mater. Today Bio., 2023, 21

[120] Hickok NJ, Shapiro IM. Immobilized antibiotics to prevent orthopaedic implant infections. Adv. Drug Deliv. Rev., 2012, 64: 1165-1176

[121] Zegre M et al. Poly(DL-lactic acid) scaffolds as a bone targeting platform for the co-delivery of antimicrobial agents against S. aureus-C.albicans mixed biofilms. Int. J. Pharm., 2022, 622: 121832

[122] Filippi M, Born G, Chaaban M, Scherberich A. Natural polymeric scaffolds in bone regeneration. Front. Bioeng. Biotechnol., 2020, 8: 474

[123] Tamay DG et al. 3D and 4D printing of polymers for tissue engineering applications. Front. Bioeng. Biotechnol., 2019, 7: 164

[124] Xue X et al. Fabrication of physical and chemical crosslinked hydrogels for bone tissue engineering. Bioact. Mater., 2022, 12: 327-339

[125] Arkenberg MR, Nguyen HD, Lin CC. Recent advances in bio-orthogonal and dynamic crosslinking of biomimetic hydrogels. J. Mater. Chem. B, 2020, 8: 7835-7855

[126] Schmidleithner C et al. Application of high resolution DLP stereolithography for fabrication of tricalcium phosphate scaffolds for bone regeneration. Biomed. Mater., 2019, 14: 045018

[127] Zeng H et al. Indirect selective laser sintering-printed microporous biphasic calcium phosphate scaffold promotes endogenous bone regeneration via activation of ERK1/2 signaling. Biofabrication, 2020, 12: 025032

[128] Mohd Pu’ad NAS et al. Review on the fabrication of fused deposition modelling (FDM) composite filament for biomedical applications. Mater. Today Proc., 2020, 29: 228-232

[129] Koons GL, Diba M, Mikos AG. Materials design for bone-tissue engineering. Nat. Rev. Mater., 2020, 5: 584-603

[130] Turnbull G et al. 3D bioactive composite scaffolds for bone tissue engineering. Bioact. Mater., 2018, 3: 278-314

[131] Amini AR, Laurencin CT, Nukavarapu SP. Bone tissue engineering: recent advances and challenges. Crit. Rev. Biomed. Eng., 2012, 40: 363-408

[132] Haleem A, Javaid M, Khan RH, Suman R. 3D printing applications in bone tissue engineering. J. Clin. Orthop. Trauma, 2020, 11: S118-S124

[133] He M et al. Layer-by-layer assembled black phosphorus/chitosan composite coating for multi-functional PEEK bone scaffold. Compos. Part B Eng., 2022, 246: 110266

[134] Sun Z et al. A dexamethasone-eluting porous scaffold for bone regeneration fabricated by selective laser sintering. ACS Appl. Bio. Mater., 2020, 3: 8739-8747

[135] Song P et al. DLP fabricating of precision GelMA/HAp porous composite scaffold for bone tissue engineering application. Compos. Part B Eng., 2022, 244: 110163

[136] Yang L et al. Coaxial bioelectrospinning of P34HB/PVA microfibers biomimetic scaffolds with simultaneity cell-laden for improving bone regeneration. Mater. Des., 2022, 213: 110349

[137] De Moraes R et al. Viability of collagen matrix grafts associated with nanohydroxyapatite and elastin in bone repair in the experimental condition of ovariectomy. Int. J. Mol. Sci., 2023, 24: 15727

[138] Manavitehrani I et al. Formation of porous biodegradable scaffolds based on poly(propylene carbonate) using gas foaming technology. Mater. Sci. Eng. C, 2019, 96: 824-830

[139] Radhakrishnan J, Muthuraj M, Gandham GSPD, Sethuraman S, Subramanian A. Nanohydroxyapatite-protein interface in composite sintered scaffold influences bone regeneration in rabbit ulnar segmental defect. J. Mater. Sci. Mater. Med., 2022, 33: 36

[140] Baek JW, Kim KS, Park H, Kim BS. Marine plankton exoskeletone-derived hydroxyapatite/polycaprolactone composite 3D scaffold for bone tissue engineering. Biomater. Sci., 2022, 10: 7055-7066

[141] Wassif RK et al. Injectable systems of chitosan in situ forming composite gel incorporating linezolid-loaded biodegradable nanoparticles for long-term treatment of bone infections. Drug Deliv. Transl. Res., 2024, 14: 80-102

[142] Qiu X et al. Experimental study of β-TCP scaffold loaded with VAN/PLGA microspheres in the treatment of infectious bone defects. Colloids Surf. B Biointerfaces, 2022, 213

[143] Shen M et al. 3D bioprinting of in situ vascularized tissue engineered bone for repairing large segmental bone defects. Mater. Today Bio., 2022, 16

[144] Wang Y et al. A recombinant parathyroid hormone‐related peptide locally applied in osteoporotic bone defect. Adv. Sci., 2023, 10: 2300516

[145] Yang C et al. 3D printed enzyme‐functionalized scaffold facilitates diabetic bone regeneration. Adv. Funct. Mater., 2021, 31: 2101372

[146] Wang C et al. Advanced reconfigurable scaffolds fabricated by 4D printing for treating critical-size bone defects of irregular shapes. Biofabrication, 2020, 12: 045025

[147] Deng Y et al. 4D printed shape memory polyurethane-based composite for bionic cartilage scaffolds. ACS Appl. Polym. Mater., 2023, 5: 1283-1292

[148] White J, Foley M, Rowley A. A novel approach to 3D-printed fabrics and garments. 3D Print. Addit. Manuf., 2015, 2: 145-149

[149] Capuana E, Lopresti F, Carfì Pavia F, Brucato V, La Carrubba V. Solution-based processing for scaffold fabrication in tissue engineering applications: a brief review. Polymers, 2021, 13: 2041

[150] Christy PN et al. Biopolymeric nanocomposite scaffolds for bone tissue engineering applications – a review. J. Drug Deliv. Sci. Technol., 2020, 55: 101452

[151] Shin M, Yoshimoto H, Vacanti JP. In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng., 2004, 10: 33-41

[152] Costantini, M. & Barbetta, A. Gas foaming technologies for 3D scaffold engineering. Funct. 3D Tissue Eng. Scaffolds 127–149 https://doi.org/10.1016/B978-0-08-100979-6.00006-9 (2018).

[153] Salerno A, Oliviero M, Di Maio E, Iannace S, Netti PA. Design of porous polymeric scaffolds by gas foaming of heterogeneous blends. J. Mater. Sci. Mater. Med., 2009, 20: 2043-2051

[154] Fereshteh, Z. Freeze-drying technologies for 3D scaffold engineering. Funct. 3D Tissue Eng. Scaffolds 151–174 https://doi.org/10.1016/B978-0-08-100979-6.00007-0 (2018).

[155] Puppi D, Chiellini F, Piras AM, Chiellini E. Polymeric materials for bone and cartilage repair. Prog. Polym. Sci., 2010, 35: 403-440

[156] Grenier J et al. Interplay between crosslinking and ice nucleation controls the porous structure of freeze-dried hydrogel scaffolds. Biomater. Adv., 2022, 139: 212973

[157] Prasad A, Sankar MR, Katiyar V. State of art on solvent casting particulate leaching method for orthopedic scaffoldsfabrication. Mater. Today Proc., 2017, 4: 898-907

[158] Liao C et al. Fabrication of porous biodegradable polymer scaffolds using a solvent merging/particulate leaching method. J. Biomed. Mater. Res., 2002, 59: 676-681

[159] Winarso R, Anggoro PW, Ismail R, Jamari J, Bayuseno AP. Application of fused deposition modeling (FDM) on bone scaffold manufacturing process: a review. Heliyon, 2022, 8: e11701

[160] Bittner SM et al. Fabrication and mechanical characterization of 3D printed vertical uniform and gradient scaffolds for bone and osteochondral tissue engineering. Acta Biomater., 2019, 90: 37-48

[161] Mazzoli A. Selective laser sintering in biomedical engineering. Med. Biol. Eng. Comput., 2013, 51: 245-256

[162] Liu FH, Lee RT, Lin WH, Liao YS. Selective laser sintering of bio-metal scaffold. Procedia. CIRP, 2013, 5: 83-87

[163] Zhang L, Yang G, Johnson BN, Jia X. Three-dimensional (3D) printed scaffold and material selection for bone repair. Acta Biomater., 2019, 84: 16-33

[164] Melchels FPW, Feijen J, Grijpma DW. A review on stereolithography and its applications in biomedical engineering. Biomaterials, 2010, 31: 6121-6130

[165] Chen Q et al. A study on biosafety of HAP ceramic prepared by SLA-3D printing technology directly. J. Mech. Behav. Biomed. Mater., 2019, 98: 327-335

[166] Ligon SC, Liska R, Stampfl J, Gurr M, Mülhaupt R. Polymers for 3D printing and customized additive manufacturing. Chem. Rev., 2017, 117: 10212-10290

[167] Ong CS et al. 3D bioprinting using stem cells. Pediatr. Res., 2018, 83: 223-231

[168] Chimene D et al. Nanoengineered ionic–covalent entanglement (NICE) bioinks for 3D bioprinting. ACS Appl. Mater. Interfaces, 2018, 10: 9957-9968

[169] Choe G, Oh S, Seok JM, Park SA, Lee JY. Graphene oxide/alginate composites as novel bioinks for three-dimensional mesenchymal stem cell printing and bone regeneration applications. Nanoscale, 2019, 11: 23275-23285

[170] Zhang X et al. 3D printed PCLA scaffold with nano‐hydroxyapatite coating doped green tea EGCG promotes bone growth and inhibits multidrug‐resistant bacteria colonization. Cell Prolif, 2022, 55: e13289

[171] Hu X et al. Fabrication of 3D gel-printed β-tricalcium phosphate/titanium dioxide porous scaffolds for cancellous bone tissue engineering. Int. J. Bioprinting, 2023, 9: 673

[172] Chang R, Nam J, Sun W. Effects of dispensing pressure and nozzle diameter on cell survival from solid freeform fabrication–based direct cell writing. Tissue Eng. Part A, 2008, 14: 41-48

[173] Wang X et al. 3D bioprinting technologies for hard tissue and organ engineering. Materials, 2016, 9: 802

[174] Dey M, Ozbolat IT. 3D bioprinting of cells, tissues and organs. Sci. Rep., 2020, 10

[175] Chaudhuri O, Cooper-White J, Janmey PA, Mooney DJ, Shenoy VB. Effects of extracellular matrix viscoelasticity on cellular behaviour. Nature, 2020, 584: 535-546

[176] Falahati M et al. Smart polymers and nanocomposites for 3D and 4D printing. Mater. Today, 2020, 40: 215-245

[177] Pinho AC, Buga CS, Piedade AP. The chemistry behind 4D printing. Appl. Mater. Today, 2020, 19: 100611

[178] Hager MD, Bode S, Weber C, Schubert US. Shape memory polymers: past, present and future developments. Prog. Polym. Sci., 2015, 49–50: 3-33

[179] Kempaiah R, Nie Z. From nature to synthetic systems: shape transformation in soft materials. J. Mater Chem. B, 2014, 2: 2357-2368

[180] Hu X et al. Novel 3D printed shape-memory PLLA-TMC/GA-TMC scaffolds for bone tissue engineering with the improved mechanical properties and degradability. Chin. Chem. Lett., 2023, 34: 107451

[181] Sadowska JM, Genoud KJ, Kelly DJ, O’Brien FJ. Bone biomaterials for overcoming antimicrobial resistance: advances in non-antibiotic antimicrobial approaches for regeneration of infected osseous tissue. Mater. Today, 2021, 46: 136-154

[182] Zheng Y et al. Neuro-regenerative imidazole-functionalized GelMA hydrogel loaded with hAMSC and SDF-1α promote stem cell differentiation and repair focal brain injury. Bioact. Mater., 2021, 6: 627-637

[183] Cheng Q et al. Dual cross-linked hydrogels with injectable, self-healing, and antibacterial properties based on the chemical and physical cross-linking. Biomacromolecules, 2021, 22: 1685-1694

[184] Beninatto R et al. Photocrosslinked hydrogels from coumarin derivatives of hyaluronic acid for tissue engineering applications. Mater. Sci. Eng. C, 2019, 96: 625-634

[185] Rosenquist J et al. An injectable, shape-retaining collagen hydrogel cross-linked using thiol-maleimide click chemistry for sealing corneal perforations. ACS Appl. Mater. Interfaces, 2023, 15: 34407-34418

[186] Guo Y et al. Recent advances in the medical applications of hemostatic materials. Theranostics, 2023, 13: 161-196

[187] Liu Y et al. Regulation of the inflammatory cycle by a controllable release hydrogel for eliminating postoperative inflammation after discectomy. Bioact. Mater., 2021, 6: 146-157

[188] Nguyen MK, Alsberg E. Bioactive factor delivery strategies from engineered polymer hydrogels for therapeutic medicine. Prog. Polym. Sci., 2014, 39: 1235-1265

[189] Jalili NA, Muscarello M, Gaharwar AK. Nanoengineered thermoresponsive magnetic hydrogels for biomedical applications. Bioeng. Transl. Med., 2016, 1: 297-305

[190] Loebel C, Rodell CB, Chen MH, Burdick JA. Shear-thinning and self-healing hydrogels as injectable therapeutics and for 3D-printing. Nat. Protoc., 2017, 12: 1521-1541

[191] Tao J et al. Injectable chitosan-based thermosensitive hydrogel/nanoparticle-loaded system for local delivery of vancomycin in the treatment of osteomyelitis. Int. J. Nanomed., 2020, 15: 5855-5871

[192] Nicodemus GD, Bryant SJ. Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng. Part B Rev., 2008, 14: 149-165

[193] Xia B, Deng Y, Lv Y, Chen G. Stem cell recruitment based on scaffold features for bone tissue engineering. Biomater. Sci., 2021, 9: 1189-1203

[194] Chen FM, Wu LA, Zhang M, Zhang R, Sun HH. Homing of endogenous stem/progenitor cells for in situ tissue regeneration: promises, strategies, and translational perspectives. Biomaterials, 2011, 32: 3189-3209

[195] Hou Y et al. Injectable degradable PVA microgels prepared by microfluidic technology for controlled osteogenic differentiation of mesenchymal stem cells. Acta Biomater., 2018, 77: 28-37

[196] Bastami, F., Safavi, S. M., Seifi, S., Nadjmi, N. & Khojasteh, A. Addition of bone-marrow mesenchymal stem cells to 3D-printed alginate/gelatin hydrogel containing freeze-dried bone nanoparticles accelerates regeneration of critical size bone defects. Macromol. Biosci. 24, e2300065 (2023).

[197] Tang Y, Tong X, Conrad B, Yang F. Injectable and in situ crosslinkable gelatin microribbon hydrogels for stem cell delivery and bone regeneration in vivo. Theranostics, 2020, 10: 6035-6047

[198] Qi X et al. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells repair critical-sized bone defects through enhanced angiogenesis and osteogenesis in osteoporotic rats. Int. J. Biol. Sci., 2016, 12: 836-849

[199] Bordukalo-Nikšić T, Kufner V, Vukičević S. The role of BMPs in the regulation of osteoclasts resorption and bone remodeling: from experimental models to clinical applications. Front. Immunol., 2022, 13: 869422

[200] Li Y et al. A sustained-release PDGF-BB nanocomposite hydrogel for DM-associated bone regeneration. J. Mater. Chem. B, 2023, 11: 974-984

[201] Helbig L et al. Bone morphogenetic proteins-7 and -2 in the treatment of delayed osseous union secondary to bacterial osteitis in a rat model. BMC Musculoskelet. Disord., 2018, 19

[202] Ratanavaraporn J, Furuya H, Kohara H, Tabata Y. Synergistic effects of the dual release of stromal cell-derived factor-1 and bone morphogenetic protein-2 from hydrogels on bone regeneration. Biomaterials, 2011, 32: 2797-2811

[203] Chen Y et al. Magnesium oxide nanoparticle coordinated phosphate-functionalized chitosan injectable hydrogel for osteogenesis and angiogenesis in bone regeneration. ACS Appl. Mater. Interfaces, 2022, 14: 7592-7608

[204] Oliveira JM et al. Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: Scaffold design and its performance when seeded with goat bone marrow stromal cells. Biomaterials, 2006, 27: 6123-6137

[205] Posadowska U et al. Injectable hybrid delivery system composed of gellan gum, nanoparticles and gentamicin for the localized treatment of bone infections. Expert Opin. Drug Deliv., 2016, 13: 613-620

[206] Xu W et al. 3D printing for polymer/particle-based processing: a review. Composites Part B: Engineering, 2021, 223: 109102

[207] Ghosh C, Sarkar P, Issa R, Haldar J. Alternatives to conventional antibiotics in the era of antimicrobial resistance. Trends Microbiol., 2019, 27: 323-338

[208] Epstein AK, Pokroy B, Seminara A, Aizenberg J. Bacterial biofilm shows persistent resistance to liquid wetting and gas penetration. Proc. Natl. Acad. Sci. USA, 2011, 108: 995-1000

[209] Vlamakis H, Chai Y, Beauregard P, Losick R, Kolter R. Sticking together: building a biofilm the Bacillus subtilis way. Nat. Rev. Microbiol., 2013, 11: 157-168

[210] Lee J, Byun H, Madhurakkat Perikamana SK, Lee S, Shin H. Current advances in immunomodulatory biomaterials for bone regeneration. Adv. Healthc. Mater., 2019, 8: 1801106

[211] Pogodin S et al. Biophysical model of bacterial cell interactions with nanopatterned cicada wing surfaces. Biophys. J., 2013, 104: 835-840

[212] Mo, S. et al. Tuning the arrangement of lamellar nanostructures: achieving the dual function of physically killing bacteria and promoting osteogenesis. Mater. Horiz. 10, 881–888 (2023).

[213] Bogatcheva E et al. Chemical modification of capuramycins to enhance antibacterial activity. J. Antimicrob. Chemother., 2011, 66: 578-587

[214] Amin Yavari S et al. Layer by layer coating for bio-functionalization of additively manufactured meta-biomaterials. Addit. Manuf., 2020, 32: 100991

[215] Agarwal R, García AJ. Biomaterial strategies for engineering implants for enhanced osseointegration and bone repair. Adv. Drug Deliv. Rev., 2015, 94: 53-62

[216] Collon K, Gallo MC, Lieberman JR. Musculoskeletal tissue engineering: regional gene therapy for bone repair. Biomaterials, 2021, 275: 120901

[217] Li X, Cao X. BMP signaling and skeletogenesis. Ann. N. Y. Acad. Sci., 2006, 1068: 26-40

[218] Niu Y, Wang Z, Shi Y, Dong L, Wang C. Modulating macrophage activities to promote endogenous bone regeneration: biological mechanisms and engineering approaches. Bioact. Mater., 2021, 6: 244-261

[219] Graney PL, Roohani-Esfahani SI, Zreiqat H, Spiller KL. In vitro response of macrophages to ceramic scaffolds used for bone regeneration. J. R. Soc. Interface, 2016, 13: 20160346

[220] Liu X et al. 3D-printed scaffolds with 2D hetero-nanostructures and immunomodulatory cytokines provide pro-healing microenvironment for enhanced bone regeneration. Bioact. Mater., 2023, 27: 216-230

[221] Liu S et al. Tissue engineering of JAK inhibitor‐loaded hierarchically biomimetic nanostructural scaffold targeting cellular senescence for aged bone defect repair and bone remolding. Adv. Healthc. Mater., 2023, 12: 2301798

[222] Poth N, Seiffart V, Gross G, Menzel H, Dempwolf W. Biodegradable chitosan nanoparticle coatings on titanium for the delivery of BMP-2. Biomolecules, 2015, 5: 3-19

[223] Sánchez-Salcedo S, Heras C, Lozano D, Vallet-Regí M, Salinas AJ. Nanodevices based on mesoporous glass nanoparticles enhanced with zinc and curcumin to fight infection and regenerate bone. Acta Biomater., 2023, 166: 655-669

[224] Sarkar N, Bose S. Liposome-encapsulated curcumin-loaded 3D printed scaffold for bone tissue engineering. ACS Appl. Mater. Interfaces, 2019, 11: 17184-17192

[225] Cheng R et al. Advanced liposome-loaded scaffolds for therapeutic and tissue engineering applications. Biomaterials, 2020, 232

[226] Ross C, Taylor M, Fullwood N, Allsop D. Liposome delivery systems for the treatment of Alzheimer’s disease. Int. J. Nanomed., 2018, 13: 8507-8522

[227] Che L et al. A biomimetic and bioactive scaffold with intelligently pulsatile teriparatide delivery for local and systemic osteoporosis regeneration. Bioact. Mater., 2023, 19: 75-87

[228] Liu A et al. Optimized BMSC-derived osteoinductive exosomes immobilized in hierarchical scaffold via lyophilization for bone repair through Bmpr2/Acvr2b competitive receptor-activated Smad pathway. Biomaterials, 2021, 272

[229] Liu W, Ma Z, Li J, Kang X. Mesenchymal stem cell-derived exosomes: therapeutic opportunities and challenges for spinal cord injury. Stem Cell Res. Ther., 2021, 12: 102

[230] Lu J, Wang QY, Sheng JG. Exosomes in the repair of bone defects: next-generation therapeutic tools for the treatment of nonunion. BioMed Res. Int., 2019, 2019: 1-11

[231] Narayanan R, Huang CC, Ravindran S. Hijacking the cellular mail: exosome mediated differentiation of mesenchymal stem cells. Stem Cells Int., 2016, 2016: 1-11

[232] Zhang Y et al. Umbilical mesenchymal stem cell-derived exosome-encapsulated hydrogels accelerate bone repair by enhancing angiogenesis. ACS Appl. Mater. Interfaces, 2021, 13: 18472-18487

[233] Guan P et al. Exosome-loaded extracellular matrix-mimic hydrogel with anti-inflammatory property Facilitates/promotes growth plate injury repair. Bioact. Mater., 2022, 10: 145-158

[234] Hao J et al. Large-sized bone defect repair by combining a decalcified bone matrix framework and bone regeneration units based on photo-crosslinkable osteogenic microgels. Bioact. Mater., 2022, 14: 97-109

[235] Wang X et al. Osteoimmune modulation and guided osteogenesis promoted by barrier membranes incorporated with S-Nitrosoglutathione (GSNO) and mesenchymal stem cell-derived exosomes. Int. J. Nanomed., 2020, 15: 3483-3496

[236] Wu Z et al. Schwann Cell-derived exosomes promote bone regeneration and repair by enhancing the biological activity of porous Ti6Al4V scaffolds. Biochem. Biophys. Res. Commun., 2020, 531: 559-565

[237] Dupont KM et al. Human stem cell delivery for treatment of large segmental bone defects. Proc. Natl. Acad. Sci., 2010, 107: 3305-3310

[238] Arvidson K et al. Bone regeneration and stem cells. J. Cell. Mol. Med., 2011, 15: 718-746

[239] Grayson WL et al. Stromal cells and stem cells in clinical bone regeneration. Nat. Rev. Endocrinol., 2015, 11: 140-150

[240] Wang H et al. Construction of vascularized tissue engineered bone with nHA-Coated BCP bioceramics loaded with peripheral blood-derived MSC and EPC to repair large segmental femoral bone defect. ACS Appl. Mater. Interfaces, 2023, 15: 249-264

[241] Qin C et al. Cell-laden scaffolds for vascular-innervated bone regeneration. Adv. Healthc. Mater., 2023, 12: e2201923

[242] Liu S et al. Synergy of inorganic and organic inks in bioprinted tissue substitutes: construct stability and cell response during long-term cultivation in vitro. Compos. Part B Eng., 2023, 261: 110804